NCT03312777View on ClinicalTrials.gov

Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

December 15, 2017

Study Completion Date

December 22, 2017

Conditions
Pain
Interventions
DRUG

Omnitram

Omnitram tablets overencapsulated

DRUG

Tramadol

Tramadol tablet overencapsulated

DRUG

Placebo

Microcrystalline powder overencapsulated

Trial Locations (1)

84124

PRA Health Sciences, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

collaborator

DF/Net Rearch

UNKNOWN

collaborator

ITT Research Institute

UNKNOWN

lead

Syntrix Biosystems, Inc.

INDUSTRY